COMMUNIQUÉS West-GlobeNewswire

Les personnes souffrant d’obésité sont discriminées
23/04/2019
OTTAWA, 23 avr. 2019 (GLOBE NEWSWIRE) -- Le second bulletin d’Obésité Canada qui évalue l’accès au traitement conclut que les Canadiens affectés par l’obésité continuent d’être ignorés par les systèmes de santé, par les [...]
Canadians with Obesity Treated as Second-Class Citizens Compared with Other Chronic Diseases: Report
23/04/2019
OTTAWA, April 23, 2019 (GLOBE NEWSWIRE) -- Obesity Canada’s second report card assessing access to treatment concludes Canadians living with obesity continue to be ignored by healthcare systems and health policy makers [...]
MJBizDaily Introduces MJBizDaily European Cannabis Symposium, Copenhagen, Denmark, May 6
23/04/2019
DENVER, April 23, 2019 (GLOBE NEWSWIRE) -- The producers of America’s oldest and largest cannabis trade show, Marijuana Business Conference & Expo (MJBizCon) , introduce MJBizDaily’s European Cannabis Symposium in [...]
Herantis Pharma Announces 12-Month Follow-Up Review from Phase 1 Lymfactin Trial in Breast Cancer-Associated Lymphedema
23/04/2019
Herantis Pharma Announces 12-Month Follow-Up Review from Phase 1 Lymfactin ® Trial in Breast Cancer-Associated Lymphedema Herantis Pharma Plc Company release 23 April 2019 at 9:00 am Herantis Pharma Plc (“Herantis”) [...]
Biocartis Group NV: Biocartis Announces Global Collaboration with Covance
23/04/2019
PRESS RELEASE : 23 April 2019, 07:00 CEST Biocartis Announces Global Collaboration with Covance Mechelen, Belgium, 23 April 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics [...]
Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 23 May 2019 have been made available
23/04/2019
Regulated information Gosselies, Belgium, 23 April 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l’assemblée générale extraordinaire du 23 mai 2019
23/04/2019
Information réglementée Gosselies, Belgique, le 23 avril 2019, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Hua Medicine Initiates First Combination Study of Dorzagliatin with SGLT-2 in the United States
23/04/2019
SHANGHAI, China, April 22, 2019 (GLOBE NEWSWIRE) -- Hua Medicine (HKEX: 2552), a Shanghai-based drug development company focused on developing a global first-in-class oral drug for the treatment of Type 2 diabetes, [...]
Extendicare Announces Nomination of Two New Directors and Agreement with Sandpiper Group
23/04/2019
MARKHAM, Ontario, April 22, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announces that it has entered into an agreement (the “Agreement”) with Sandpiper Group, which holds 9% of [...]
National Research Corporation to Broadcast its 2019 First Quarter Conference Call Live on the Internet
22/04/2019
Lincoln, Nebraska, April 22, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2019 first quarter earnings conference call on [...]
Chembio Diagnostics to Report First Quarter 2019 Financial Results on May 1, 2019
22/04/2019
MEDFORD, N.Y., April 22, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Eve & Co Announces Board Appointment of Alice Murphy
22/04/2019
TORONTO, April 22, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that Alice Murphy has been appointed to its Board of Directors. [...]
Development Veteran Steven J. Knox Joins Assembly Biosciences as Senior Vice President, Clinical Development
22/04/2019
SAN FRANCISCO, April 22, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
U.S. Food and Drug Administration Accepts Biologics License Application for Eptinezumab
22/04/2019
BOTHELL, Wash., April 22, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Gritstone Oncology Announces Proposed Public Offering of Common Stock
22/04/2019
EMERYVILLE, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq:GRTS) today announced that it has commenced an underwritten public offering of 6,500,000 shares of common stock. All of the shares [...]
Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
22/04/2019
SAN DIEGO, April 22, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (Nasdaq:TPTX), a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, today [...]
CytomX Therapeutics Appoints Elaine V. Jones, Ph.D., to Board of Directors
22/04/2019
SOUTH SAN FRANCISCO, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Nuvectra to Report First Quarter 2019 Financial Results on May 1, 2019
22/04/2019
PLANO, Texas, April 22, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended [...]
OrthoPediatrics Corp. Announces Licensing Partnership with CoorsTek Medical
22/04/2019
WARSAW, Ind., April 22, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce a [...]

Pages